ADAM33 and retinoblastoma: Moreover, genome-wide methylation profiling of aqueous humor cfDNA has defined robust subtypes of retinoblastoma linked to clinical outcomes, identifying differentially methylated genes (e.g., TFF1, BCHE, PCDHB2, ADAM33) that correlate with aggressive disease and chemoresistance.